Transpek Inds Stock Price Today (NSE: TRANSPEK)
Fundamental Score
Transpek Inds Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Transpek Inds share price today is ₹1392.00, up +0.00% on NSE/BSE as of 18 June 2026. Transpek Inds (TRANSPEK) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹729.22 (Cr). The 52-week high for TRANSPEK share price is ₹1749.50 and the 52-week low is ₹1361.55. At a P/E ratio of 12.55x, TRANSPEK is currently trading below its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of 7.75% and a debt-to-equity ratio of 0.05.
Transpek Inds Share Price Chart — NSE/BSE Historical Performance
Transpek Inds share price chart: -16.19% return over the past month. 52-week high ₹1749.50, 52-week low ₹1361.55.
Transpek Inds — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1412.00 | ₹1429.95 | ₹1361.55 | ₹1392.00 | 4.38K (Cr) | |
| ₹1436.00 | ₹1454.00 | ₹1410.00 | ₹1413.30 | 2.27K (Cr) | |
| ₹1475.85 | ₹1491.00 | ₹1435.00 | ₹1437.75 | 2.42K (Cr) | |
| ₹1466.00 | ₹1498.95 | ₹1425.00 | ₹1468.55 | 2.82K (Cr) | |
| ₹1522.00 | ₹1522.00 | ₹1430.00 | ₹1453.85 | 10.57K (Cr) | |
| ₹1564.80 | ₹1577.00 | ₹1511.00 | ₹1519.60 | 2.12K (Cr) | |
| ₹1619.80 | ₹1640.00 | ₹1534.00 | ₹1548.65 | 7.60K (Cr) | |
| ₹1640.00 | ₹1660.00 | ₹1601.00 | ₹1615.05 | 7.39K (Cr) | |
| ₹1613.30 | ₹1649.40 | ₹1613.30 | ₹1632.75 | 2.30K (Cr) | |
| ₹1640.05 | ₹1671.95 | ₹1611.40 | ₹1629.25 | 3.73K (Cr) |
Transpek Inds — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1651.00 | ₹1693.80 | ₹1361.55 | ₹1392.00 | -15.69% | |
| ₹1660.00 | ₹1738.00 | ₹1606.60 | ₹1667.35 | +0.44% | |
| ₹1749.00 | ₹1749.50 | ₹1600.10 | ₹1648.45 | -5.75% |
AI Research Briefing
Powered by Gemini · 2026-04-20
Small-cap chemicals play with weak growth, promoter games, and high liquidity risk make it an avoidable story.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Recent announcements include routine regulatory filings regarding disclosures as a Large Corporate.
CORE STORY (THE REAL GAME)
Transpek is a play on the growth of the Indian specialty chemicals sector, supplying key inputs to diverse industries. The market narrative hinges on its ability to capitalize on domestic demand and export opportunities amid global shifts away from China.
- Favorable industry growth in Indian chemical sector
- Promoter stake increase (inter-se transfer)
- Improved EBITDA margins in recent quarter
- Significant order wins
- Breakthrough product innovation
- Successful expansion into new geographies
- Small-cap liquidity risk
- Weak revenue and profit growth
- Dependence on imported raw materials
FII and DII holdings are minimal and decreasing, suggesting limited institutional interest.
Moderate global growth in the chemical industry, with India projected to see a 10.9% increase in chemical production in 2026.
Free Cash Flow positive over 5 years at ₹271.46 Cr, but needs to be monitored for consistency.
Transpek's 3-6 month outlook depends on its ability to capitalize on industry growth and manage raw material costs. Focus on higher value-added products is crucial.
Primary Thesis Risk
Inability to achieve sustainable revenue and profit growth will crush the valuation.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Transpek Inds Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Transpek Inds Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TRANSPEK across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (16.16%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 12.55 vs Industry: 20.98)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (32.36%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹271.46 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (57.47%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (7.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Limited Growth History (2.81% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-5.59% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-5.59% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Limited Institutional Interest (FII+DII: 1.67%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Transpek Inds vs Commodity Chemicals Peers
Peer Comparison - Commodity Chemicals
Compare Transpek Inds with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Transpek IndsTranspek Inds...Selected✓ TRANSPEK • 506687 | 41.6/100 | ₹1392.00₹1392 | ₹729.22₹729.22 | 12.55Average 12.6 Average | 7.75%Poor 7.75% Poor | 10.02%Average 10.02% Average | 0.05Excellent 0.1 Excellent | -5.59%Poor -5.59% Poor | 2.81%Average 2.81% Average | 1.53% |
SRF LtdSRF Ltd... SRF • 503806 | 49.8/100 | ₹2736.80₹2737 | ₹86606.52₹86606.52 | 53.54Average 53.5 Average | 10.37%Average 10.37% Average | 12.27%Average 12.27% Average | 0.35Excellent 0.3 Excellent | 4.40%Average 4.40% Average | 15.30%Excellent 15.30% Excellent | 0.25% |
Tata Chemicals LtdTata Chemicals ... TATACHEM • 500770 | 14.9/100 | ₹774.55₹775 | ₹20261.08₹20261.08 | 62.18Average 62.2 Average | 1.20%Poor 1.20% Poor | 3.96%Poor 3.96% Poor | 0.34Excellent 0.3 Excellent | -47.92%Poor -47.92% Poor | 7.53%Good 7.53% Good | 1.38% |
Deepak Fertilisers and Petrochemicals Corporation LtdDeepak Fertilis... DEEPAKFERT • 500645 | 57/100 | ₹1448.30₹1448 | ₹17120.52₹17120.52 | 17.39Average 17.4 Average | 15.56%Good 15.56% Good | 15.67%Good 15.67% Good | 0.68Good 0.7 Good | 94.55%Excellent 94.55% Excellent | 17.00%Excellent 17.00% Excellent | 0.74% |
52.8/100 | ₹516.15₹516 | ₹7381.56₹7381.56 | 11.61Average 11.6 Average | 7.08%Poor 7.08% Poor | 9.57%Poor 9.57% Poor | 0.00Excellent 0.0 Excellent | 3.30%Average 3.30% Average | 8.86%Good 8.86% Good | 3.58% | |
Ghcl LtdGhcl Ltd... GHCL • 500171 | 40.4/100 | ₹463.10₹463 | ₹5520.31₹5520.31 | 9.69Average 9.7 Average | 18.57%Good 18.57% Good | 24.19%Excellent 24.19% Excellent | 0.03Excellent 0.0 Excellent | 8.63%Good 8.63% Good | -0.75%Poor -0.75% Poor | 2.09% |
Blue Pearl Agriventures LtdBlue Pearl Agri... BPAGRI • 514440 | 19.7/100 | ₹17.52₹18 | ₹5397.73₹5397.73 | 9306.43Average 9306.4 Average | 2.12%Poor 2.12% Poor | 2.57%Poor 2.57% Poor | 0.00Excellent 0.0 Excellent | — — | 173.71%Excellent 173.71% Excellent | 0.00% |
Chemplast Sanmar LtdChemplast Sanma... CHEMPLASTS • 543336 | 24.4/100 | ₹222.23₹222 | ₹4503.74₹4503.74 | — — | -5.93%Poor -5.93% Poor | 1.83%Poor 1.83% Poor | 0.97Good 1.0 Good | — — | 28.15%Excellent 28.15% Excellent | 0.00% |
Tanfac Industries LtdTanfac Industri... TANFACIND • 506854 | 68.7/100 | ₹1971.70₹1972 | ₹4106.65₹4106.65 | 43.66Average 43.7 Average | 32.05%Excellent 32.05% Excellent | 41.76%Excellent 41.76% Excellent | 0.09Excellent 0.1 Excellent | 38.64%Excellent 38.64% Excellent | 27.58%Excellent 27.58% Excellent | 0.22% |
Gujarat Alkalies and Chemicals LtdGujarat Alkalie... GUJALKALI • 530001 | 28/100 | ₹687.35₹687 | ₹3866.17₹3866.17 | 25774.49Average 25774.5 Average | -1.13%Poor -1.13% Poor | -0.34%Poor -0.34% Poor | 0.11Excellent 0.1 Excellent | — — | 8.37%Good 8.37% Good | 3.01% |
Grauer & Weil India LtdGrauer & Weil I... GRAUWEIL • 505710 | 59.7/100 | ₹72.27₹72 | ₹3614.14₹3614.14 | 23.93Average 23.9 Average | 17.58%Good 17.58% Good | 23.34%Excellent 23.34% Excellent | 0.01Excellent 0.0 Excellent | 17.17%Excellent 17.17% Excellent | 12.90%Good 12.90% Good | 0.63% |
Top Commodity Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- SRF Ltd share price86606.52 Cr
- Tata Chemicals Ltd share price20261.08 Cr
- Deepak Fertilisers and Petrochemicals Corporation Ltd share price17120.52 Cr
- Gujarat Narmada Valley Fertilizers & Chemicals Ltd share price7381.56 Cr
- Ghcl Ltd share price5520.31 Cr
Transpek Inds PE Ratio History
Historical price-to-earnings ratio for TRANSPEK — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹87.25 | ₹1392.00 | 16x |
| FY 2024 | ₹69.03 | ₹1583.05 | 22.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Transpek Inds Dividend History
Annual cash dividends paid by TRANSPEK — dividend yield 1.53%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹7.82 Cr |
| FY 2024 | ₹15.36 Cr |
| FY 2023 | ₹12.57 Cr |
| FY 2022 | ₹4.19 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Transpek Inds Quarterly Performance
Latest quarterly metrics for TRANSPEK — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-1.49%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
32.36%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
2.81%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-5.59%
Compounded annual net profit growth over 5 years
Transpek Inds Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TRANSPEK — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Transpek Inds Financial Statements
Annual income statement, balance sheet and cash flow for Transpek Inds (TRANSPEK) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Transpek Inds
About TRANSPEK (Transpek Inds)
Transpek Inds (TRANSPEK) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Commodity Chemicals sector with a curr...ent market capitalisation of ₹729.22 (Cr). Transpek Inds has delivered a Return on Equity (ROE) of 7.75% and a ROCE of 10.02%. The debt-to-equity ratio stands at 0.05, reflecting the company's capital structure. Investors tracking TRANSPEK share price can monitor key metrics including P/E ratio, promoter holding of 57.47%, and quarterly earnings growth.
Company Details
Latest News
TRANSPEK Share Price: Frequently Asked Questions
What is the current share price of Transpek Inds?
Transpek Inds (TRANSPEK) trades at ₹1392.00 on NSE and BSE. Market cap ₹729.22 (Cr). Educational data only.
What is the P/E ratio of Transpek Inds?
Transpek Inds has a P/E of 12.55x vs industry average 20.98x.
What is the Bull Run score for Transpek Inds?
Transpek Inds has a Bull Run score of 41.6/100 based on 25+ financial parameters.
Does Transpek Inds pay dividends?
Transpek Inds has a dividend yield of 1.53%. Past dividends don't guarantee future payments.
What is the ROE of Transpek Inds?
Transpek Inds has ROE of 7.75%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Transpek Inds?
Transpek Inds has debt-to-equity of 0.05.
Is Transpek Inds a good investment?
Bull Run gives Transpek Inds a score of 41.6/100. This is not investment advice — consult a SEBI-registered advisor.